Aeternum Health Inc.: Aeternum Announces Acquisition of an Option to Acquire 51% of American Renaissance Minerals, Sponsor of the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon
Aeternum Health Inc. (OTC: AETN) said it acquired an option to buy a 51% stake in American Renaissance Minerals (ARM), which is developing Cameroon’s Nkamouna cobalt-nickel-manganese project. ARM is working with Cameroon to secure a new permit. A historical estimate cited 323 million tonnes at 0.21% cobalt, 0.61% nickel and 1.26% manganese.
How this was made
The 30-second read
Why it matters
Aeternum’s option to control 51% of ARM is intended to shorten the study-to-production path by leveraging licensed historical technical work and by supporting a new permit award free of prior encumbrance.
Market read
Traders may reprice AETN on the probability-weighted chance of a permit restart and concentrator build, but should monitor option terms, financing, and updated resource work.
What to watch
The article emphasizes a historical resource estimate not compliant with current SEC standards and provides no confirmation path or updated resource conversion schedule, leaving technical and permitting execution risk underappreciated.
Background
Aeternum is positioning as a strategic supplier of critical minerals; ARM’s Nkamouna project previously lost momentum when the prior permit was withdrawn in Feb 2025.
Ticker impact
Aeternum acquired an option to buy a 51% stake in American Renaissance Minerals to develop the Nkamouna cobalt-nickel-manganese project in Cameroon.
Near-term sentiment likely positive for Aeternum on deal clarity, but follow-through risk remains high until permit and financing milestones are achieved.
The article discloses a fresh acquisition option and specific project restart rationale (new permit free of encumbrance, concentrator plan, capital and engineering contribution). However, it does not provide deal economics, option exercise terms, or funding commitments, limiting certainty on valuation impact.
Market effects
Reinforces the critical-minerals project pipeline narrative (cobalt/nickel) and highlights concentrator-at-site development as a value-retention strategy.
Cameroon permit re-issuance and state free-carried interest structure may attract additional attention to Cameroon’s mining code implementation.
US strategic-interest framing and import reliance on cobalt/nickel can support broader investor appetite for non-DRC cobalt and diversified nickel supply projects.
Counterpoint
The option to acquire 51% does not equal ownership or production; without disclosed option price, exercise conditions, and financing, the market may overreact to a still-uncertain restart timeline.
Key entities
- companyAeternum Health Inc.
OTC-listed company (AETN) acquiring an option to buy 51% of ARM to develop the Nkamouna cobalt-nickel-manganese project.
- companyAmerican Renaissance Minerals
Vehicle advancing the Nkamouna project in Cameroon, owned by American Renaissance Resources private equity.
- companyGeovic Ltd.
Majority owner of the prior permit holder; licensed historical technical information and will release claims under the Jan 2026 agreement.
- governmentGovernment of Cameroon
Working counterpart for a new mining permit under the Dec 2023 Mining Code, including a 10% state free-carried interest.
